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monitoring procedure is highly-efficient. Also, the establishment of stan-
dards of testing specimen can avoid contamination.
Conclusions: Most departments are highly satisfied with the program
because of increased work efficiency. In future, this program can be consid-
ered to contribute to inspect test results of epidemic outbreak and do ‘qual-
ity assurance’ of the medical practice directly related to infection control as
well as consistent monitoring will be needed.PS 2-330
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Purpose: The purpose of this study was to establish a CVBSI Bundles Informa-
tion System which composes the idea of integrated prevent Central Line-
Associated Bloodstream Infections. And constructed a convenience for elec-
tronic documentation, data storage, benefit evaluation and a platform from
medical team member communication.
Methods: CVBSI Bundles Information System was based on the hospital infor-
mation system (HIS) and constructed into 5 pages, there could print pa-
tients’ care information out from the system and reduce duplication
writing. All the hospital ICN was in-charge central line management. Statis-
tical analysis of the system function could be used as basis for assessing the
quality of related work.
Results: Compare to last year, daily assessment and maintenance of central
lines adherence rate were increased from 48.5% to 90.9% and 22.9% to 86.4%,
Central Line-Associated Bloodstream Infection rate was decreased\ from
4.8&to 3.0&, cost down 621,720NT$.
Conclusions: CVBSI Bundles Information System did simplify the operation
and handwritten medical records, reduce the Central Line-Associated
Bloodstream infections rate and cost down.PS 2-331
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Purpose: Klebsiella pneumoniae (Kp) is a well-known pathogen and a com-
mon reason of community-acquired and nosocomial infections causing liver
abscesses, endophthalmitis, or meningitis. Capsular polysaccharide (CPS) is
one of the most important virulent factors in Kp. The virulence effect caused
by wzi gene that is involved in the attachment of the repeat unit of CPS to
outer membrane remains uncertain. Previous studies indicate that deduced
Wzi protein sequence is corresponding to capsular serotype (K-type). This
study aimed to examine the gene actual effect on virulence and its changes
associated with K-type switch.
Methods: In-frame deletion and replacement was used to obtain the dele-
tion and switched mutants of the wzi gene in Kp strain 312, which isolated
from liver abscess patient and harbored K20 CPS cluster. The wzi gene of
switched mutant was replaced from K20-type to K1-type. The virulence
was assessed through serum killing, neutrophil phagocytosis and mouse
lethality assay.
Results: Comparison to the parental 312 strain (K20, serum-sensitive, phago-
cytosis-resistant, LD50Z10
2 cfu), 312D wzi mutant decreased 102-fold ofLD50 and exhibited more susceptible in serum killing and phagocytosis.
LD50 of 312D wzi::K1-wzimutant was 10
3 cfu and there was no significant dif-
ference in virulence assay between 312D wzi and 312D wzi::K1-wzi strains.
Conclusions: The study demonstrates that wzi gene has impact in virulence
in mice model, and contributes to serum killing and phagocytosis of Kp
strains. Furthermore, replacement of distinct K-type wzi gene can also influ-
ence the mice lethality.PS 2-332
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Purpose: Klebsiella pneumoniae carbapenemase (KPC) is one of the most
common carbapenemases. KPC-2-containing K. pneumoniae with sequence
type (ST) 258 and ST 11 clones have been the most worldwide spread. We
report a patient with two KPC new variants (KPC-17 and KPC-22) recovered
from a patient in a nursing home.
Case report
An 86 year-old woman had stayed in a nursing home for 5 month. She was
admitted to the hospital due to acute delirium on March 21, 2014. Brain CT
showed mild cerebral atrophy. Laboratory data showed hemogram, 10.5 g/
dL; WBC, 14,900/mL; CRP, 63.9 mg/L; and creatinine, 2.8 mg/dL. CXR
showed mild bronchiectasis with probably superimposed infection. Empirical
antibiotic was ceftazidime. The sputum culture yielded mixed normal flora.
The blood and urine cultures showed no growth. However, CRP rose to 114.0
mg/L on March 31. Fosfomycin was added. The blood and sputum cultures
showed no significant bacteria, but the urine culture yielded yeast-like
organism. A CRP rose to 135.3 mg/L on April 7. Thus doripenem and
fluconazole were used. Then condition was stable and she was discharged to
a nursing home on April 14. On June 19, 2014, she returned with a fever of
38C. Urine routine showed WBC, 50-99/HPF; leukocyte esterase 3+ and
bacilli 3+. Co-amoxiclav was used for 7 days. The urine yielded imipenem-
resistant K. pneumoniae (IRKP), only susceptible to amikacin, gentamicin,
tigecycline and co-trimoxazole. On July 9, she had a fever of 38.1C. Urine
showed pyuria and IRKP, additionally resistant to tigecycline. Co-trimoxa-
zole was used for 7 days and eradicated the IRKP. PCR for blaKPC in the
plasmid of the IRKP isolates and DNA sequencing confirmed blaKPC-17 in 1st
IRKP and a new variant blaKPC-22 (GenBank acc no. KM379100) in 2nd IRKP.
Conclusions: We report two nursing home-acquired blaKPC-17- and blaKPC-22-
harboring IRKP isolates. Clinicians should be alert to IRKP, which may be a
KPC variant.PS 2-333
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Middle East Respiratory Syndrome (MERS) is a viral respiratory illness caused
by a coronavirus called MERS-CoV. It was first reported in Saudi Arabia in
2012 and has since spread to various Middle Eastern, European, North African
and Asian countries. In this case study, we report a 54-year-old man who
became the first laboratory-confirmed case of MERS-CoV infection in
Malaysia, as well as in Asia (outside Middle East), and also the first death
in this region due to the infection. He had underlying diabetes mellitus,
complaining of cough, fever and shortness of breath for 2 days with recent
visit to Middle East. Chest radiograph show a consolidation at the right
midzone. Blood investigations showed a normal haemoglobin and white cell
count with platelet 127 000/mm3, creatinine 132 micromol/L, urea 11
mmol/L, CK 935 mmol/L, ALT 62 mmol/L and AST 145 mmol/L. He was
started on intravenous Amoxycillin-Clavulanate acid, oral Erythromycin,
and oral Oseltamivir for pneumonia and throat swab was sent for MERS-
